glutathione transferase purpose transferases as mediators of signaling pathways involved in cell proliferation and cell death Molecular and Cellular Characterization of
Description
iu ny gip sn phm ph hp vi c nhng ngi nhy cm vi mi hng

UnlockAnswerUnlock Transcribed image text: 1

doi: 10.1084/jem.20111627 91 TamburiniBABurchillMAKedlRM

Volasertib was tested in patients with metastatic NSCLC and BI 2536 was examined in patients with relapsed SCLC, both with minimal efficacy, which unfortunately has been the trend for this class of inhibitor with lung cancers.126, 127, 128 New inhibitors have continued to be developed, and there is an ongoing clinical trial with a novel PLK1 inhibitor, onvansertib, in patients with chemo-resistant SCLC (ClinicalTrials.gov: NCT05450965)

A.LiuH.CornblattG.et al (2019)
